{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-010584","form_type":"8-K","ticker":"BIAF","cik":"0001712762","company_name":"bioAffinity Technologies, Inc.","filed_at":"2026-03-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.979103+00:00","generated_at":"2026-05-15T10:32:48.517457+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"bioAffinity case study shows CyPath Lung avoided invasive biopsy in high-risk nodule patient","bullets":["71-year-old former smoker with multiple lung nodules received CyPath Lung 'Unlikely Malignancy' result.","Physician delayed invasive biopsy based on test result; follow-up CT showed nodules resolved or stable.","CyPath Lung demonstrated 92% sensitivity, 87% specificity, 88% accuracy in clinical study for nodules <20mm.","Case study underscores noninvasive test's potential to reduce patient anxiety and lower healthcare costs."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-010584","json":"https://secwatch.observer/filing/0001493152-26-010584.json","markdown":"https://secwatch.observer/filing/0001493152-26-010584.md","text":"https://secwatch.observer/filing/0001493152-26-010584.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1712762/000149315226010584/0001493152-26-010584-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1712762/000149315226010584/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T10:32:48.517457+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}